×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| Supriya Lifescience Limited | 1477.48 | 347.9 | 1450.74 | 4.32 | 5,249 | 29.5 |
| SUVEN LIFE SCIENCES LTD. | 24.56 | -147.79 | 18.67 | -0.68 | 5147 | |
| SEQUENT SCIENTIFIC LTD. | 525.5 | 33.7 | 410.7 | 0.13 | 4684 | 155.0 |
Supriya Lifescience Limited, with Security Code 543434, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 142.3 | 132.0 | 140.1 | 140.1 | 158.2 | 160.6 | 166.1 | 185.6 | 184.1 | 145.1 |
| Expenses | 87.2 | 87.5 | 108.3 | 98.6 | 102.7 | 98.1 | 101.4 | 119.7 | 116.5 | 93.4 |
| Operating Profit | 55.0 | 44.5 | 31.8 | 41.5 | 55.5 | 62.5 | 64.7 | 66.0 | 67.6 | 51.7 |
| OPM % | 38.69% | 33.7% | 22.66% | 29.62% | 35.09% | 38.94% | 38.96% | 35.53% | 36.72% | 35.64% |
| Other Income | 2.0 | 2.9 | 2.5 | 3.1 | 2.2 | 2.2 | 2.5 | 2.1 | 3.0 | 2.7 |
| Interest | 0.7 | 0.8 | 0.5 | 0.5 | 0.6 | 0.3 | 0.4 | 0.5 | 0.4 | 0.5 |
| Depreciation | 3.0 | 4.0 | 4.0 | 4.0 | 3.9 | 4.7 | 4.7 | 5.0 | 6.1 | 6.5 |
| Profit before tax | 53.3 | 42.6 | 29.8 | 40.1 | 53.2 | 59.8 | 62.1 | 62.6 | 64.1 | 47.4 |
| Tax % | -28.3% | -33.1% | -19.8% | -25.7% | -30.5% | 25.3% | 25.6% | 25.2% | -21.2% | 26.6% |
| Net Profit | 38.2 | 28.5 | 23.9 | 29.8 | 36.9 | 44.6 | 46.1 | 46.8 | 50.4 | 34.8 |
| EPS in Rs | 4.75 | 3.54 | 2.97 | 3.7 | 4.59 | 5.54 | 5.71 | 5.82 | 0 | 4.32 |
No Consolidated data available.
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 15% |
| 3 Years: | 13% |
| TTM: | 21% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 25% |
| 3 Years: | -1% |
| TTM: | 45% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 27% |
| 1 Year: | 97% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| 1 Year: | 0% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|